TELA TELA Bio, Inc.
Healthcare$0.81-8.55%ClosedMarket Cap: $36.4M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-9.80
P/S
0.49
EV/EBITDA
-1.71
DCF Value
$1.17
FCF Yield
-75.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
67.3%
Operating Margin
-41.8%
Net Margin
-49.3%
ROE
-1344.5%
ROA
-57.0%
ROIC
-64.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $19.1M | 65.7% | $-10.5M | $-12.3M | $— | — |
| Q4 null | $20.9M | 65.9% | $-6.6M | $-9.0M | $— | — |
| FY null | $80.3M | 67.7% | $-33.8M | $-38.8M | $— | — |
| Q3 null | $20.7M | 67.5% | $-7.6M | $-8.6M | $— | — |
| Q2 null | $20.2M | 69.8% | $-9.1M | $-9.9M | $— | — |
| Q1 null | $18.5M | 67.6% | $-10.5M | $-11.3M | $— | — |
| Q4 null | $17.6M | 63.6% | $-8.4M | $-9.2M | $— | — |
| FY null | $69.3M | 67.1% | $-34.1M | $-37.8M | $— | — |
| Q3 null | $19.0M | 67.8% | $-9.4M | $-10.4M | $— | — |
| Q2 null | $16.1M | 68.8% | $-11.6M | $-12.6M | $— | — |
| Q1 null | $16.6M | 68.3% | $-4.8M | $-5.7M | $— | — |
| Q4 2023 | $17.0M | 68.4% | $-12.3M | $-12.9M | $-0.53 | — |